Diagnosis and Treatment of Osteoporosis
1993; Annual Reviews; Volume: 44; Issue: 1 Linguagem: Inglês
10.1146/annurev.me.44.020193.001405
ISSN1545-326X
Autores Tópico(s)Bone health and treatments
ResumoCD40 is a cell-surface member of the TNF (tumor necrosis factor) receptor superfamily. Upon activation, CD40 can license dendritic cells to promote antitumor T cell activation and re-educate macrophages to destroy tumor stroma. Numerous agonist CD40 ...Read More
Referência(s)